Flying high on obesity success, Novo's appetite for deals grows | WKZO | Everything Kalamazoo
By Natalie Grover LONDON (Reuters) - Buoyed by the success of its diabetes and obesity drugs, Novo Nordisk is on the prowl for partnerships and deals ...
Stay updated with breaking news from Corvidia Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Natalie Grover LONDON (Reuters) - Buoyed by the success of its diabetes and obesity drugs, Novo Nordisk is on the prowl for partnerships and deals ...
LONDON (Reuters) - Buoyed by the success of its diabetes and obesity drugs, Novo Nordisk is on the prowl for partnerships and deals to beef up its pipeline, a senior company executive said on Thursday. | 10:39am
EQS-News: ABIVAX / Key word: Personnel Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair 05.04.2023 / 19:30 CET/CEST The issuer is solely... | April 5, 2023
Abivax Appoints Marc de Garidel as Chief Executive Officer and Interim ...
Marc's appointment bolsters Abivax's position as a leader in the field of chronic inflammatory bowel diseasesCorinna zur Bonsen-Thomas steps down as acting Chair and remains a Board MemberProf. Hartmut